• The-year-of-more.png
  • Speaking of Your Health 3/23/2021

    • Share:
    March 25, 2021
     
     
     
     
     
    Stereotactic Radiosurgery Improves Patient Outcomes
     
    The treatment of metastatic cancer in the brain has improved considerably over the years with advancements in radiation oncology and neurosurgery. One form of treatment available at McLeod Regional Medical Center that is enhancing patient outcomes involves stereotactic radiosurgery (SRS).
     
    Stereotactic radiosurgery, a non-surgical radiation therapy, treats cancerous tumors in the brain and spine. This form of treatment allows the McLeod Radiation Oncology team to deliver precisely-targeted radiation with sub-millimeter accuracy in a fewer number of treatments offering patients more convenience and a better quality of life.
     
    The radiation is focused onto the area of disease to completely cover it with the dose necessary to overwhelm all of the abilities of a cancer cell to defend itself. This non-invasive, painless treatment utilizes a set of multiple beams that intersect at a single point on the tumor. The beams remain focused on the area as the linear accelerator rotates around the patient's head.
     
     
    Radiation Oncologist Dr. T. Rhett Spencer has been treating patients at McLeod Regional Medical Center for more than 30 years.
     
    Board Certified in Radiation Oncology, he is also the Chairman of the McLeod Cancer Conference Board.
     
    Dr. Spencer received his medical degree from the Medical University of South Carolina (MUSC) in Charleston. He also completed his residency and internship at MUSC. 
     
     
     
     
     
     
     
     
     
     
     
     
    Contact:
    Tracie Foster
    tfoster@mcleodhealth.org, (843) 777-5493